SBI Life stock rating upgraded to Buy by Kotak on higher growth forecasts

Kotak has upgraded SBI Life Insurance Co Ltd (SBILIFE:IN) to 'Buy' from 'Add,' raising its price target to INR2,250.00 from INR1,950.00. This upgrade is primarily driven by revised medium-term APE growth forecasts of 17% for FY2026-28E and an increased NBV multiple to 14.7X in its appraisal framework. Although Kotak trimmed near-term embedded value estimates by 0.7-1.8% and reduced the VNB margin forecast to 26%, it still anticipates strong operating RoEV of 17-18% and a 14% VNB CAGR for FY2025-28E, signaling confidence in the insurer's future operational performance.

Analysis

Kotak has upgraded SBI Life Insurance (SBILIFE:IN) to 'Buy' from 'Add', increasing its price target by 15.4% to INR2,250.00 from INR1,950.00. This revision is primarily driven by a more optimistic medium-term outlook, with projected FY2026-28E Annualized Premium Equivalent (APE) growth raised to 17% from a prior 15% estimate. The valuation framework has been significantly adjusted, with the New Business Value (NBV) multiple expanding to 14.7X from 11.4X, which, combined with a rollover to September 2027E estimates, accounts for the substantial price target hike. This bullish stance persists despite some near-term headwinds, including a 0.7-1.8% cut in near-term embedded value estimates and a reduction in the Value of New Business (VNB) margin forecast fatores to 26% from 28.5%. However, Kotak notes that the revised 26% VNB margin remains competitive, being higher than or in line with most industry peers. The firm's confidence is further supported by expectations of a strong 17-18% operating Return on Embedded Value (RoEV) and a 14% VNB Compound Annual Growth Rate (CAGR) for the FY2025-28E period.

Key Decisions for Investors

• Investors should view the upgrade and significant price target increase as a bullish signal, driven by Kotak's confidence in SBI Life's medium-term growth trajectory and its willingness to apply a higher valuation multiple.
• It is crucial to monitor aintenance of the VNB margin around the revised 26% forecast in coming quarters, as this metric is a key assumption underpinning the new valuation despite its recent reduction.
• Consider the projected 17-18% operating RoEV and 14% VNB CAGR as key performance indicators to track, as meeting these targets is essential to justifying the valuation rerating and achieving the INR2,250 price target.